Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Henry Schein' returned 170 results - Page 1 of 9   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Henry Schein, Inc.   Wright Investors' Service, Feb 2012, Pages: 43 , examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Henry Schein, Inc.. There is a textual review of the financial results of Henry Schein, Inc Henry Schein, Inc. - SWOT Analysis   Datamonitor, Aug 2011, Pages: 28 Henry Schein, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Henry Schein, Inc. - SWOT Analysis examines the company’s key business Henry Schein, Inc.   Sheila Greco Associates, May 2011, Pages: 3 Henry Schein, a Fortune 500(R) company and a member of the NASDAQ 100(R) Index, is recognized for its excellent customer service and highly competitive prices. The Company`s four business groups Henry Schein, Inc. - Strategy and SWOT Report   Datamonitor, Oct 2011, Pages: 41 Henry Schein, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service Henry Schein Inc (09-Dec-2010)   Directors Deals Ltd, Dec 2010, Pages: 1 Donald Kabat, (Non-Executive) of Henry Schein Inc [market cap £3457million] bought 1,000 shares at 59.780USD, holding is now 13,422 shares; representing 0.015 percent of the shares on issue. Holding Henry Schein Inc (07-Mar-2011)   Directors Deals Ltd, March 2011, Pages: 1 Three Directors at Henry Schein Inc [market cap £3878million] sold after exercising options/sold 91,909 shares at between 10.947USD and 68.120USD. Total trade value was £3 Henry Schein Inc (08-Mar-2011)   Directors Deals Ltd, March 2011, Pages: 1 Seven Directors at Henry Schein Inc [market cap £3903million] gave away/sold after exercising options/sold 143,104 shares at between 0.000USD and 62.979USD. Total trade value was £5 Henry Schein Inc-Deals & Alliances Report   Life Science Analytics, March 2011, Pages: 60 Henry Schein Inc-Deals & Alliances ReportReport contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category Henry Schein Inc-Deals & Alliances Report   Life Science Analytics, March 2011, Pages: 60 Henry Schein Inc-Deals & Alliances ReportReport contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category Henry Schein, Inc.   Datamonitor, Sep 2008, Pages: 27 The Henry Schein, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations (HSIC)HENRY SCHEIN - Quantitative Valuation Report   ValuEngine, Inc., Feb 2012, Pages: 12 well-known stock-picking styles. Note: Publications are updated on a daily basis and you will receive the most recent publication when you order. United States (HSIC)HENRY SCHEIN - Quantitative Henry Schein, Inc. (HSIC) - Financial and Strategic SWOT Analysis Review   GlobalData, May 2011, Pages: 51 Henry Schein, Inc. (HSIC) - Financial and Strategic SWOT Analysis Review Summary Henry Schein, Inc. (Henry Schein) is engaged in distributing healthcare products and services principally to office Henry Schein, Inc. Strategic Analysis Profile   Global Markets Direct, Jan 2008, Pages: 46 - The Henry Schein, Inc. Strategic Analysis Profile is a comprehensive profile of the company including both quantitative and qualitative research. The report examines the company’s business JPMorgan Healthcare Conference - Henry Schein, Inc. - Earnings Transcript   FactSet, Jan 2012 JPMorgan Healthcare Conference - Henry Schein, Inc. - Earnings Transcript Tuesday, January 10, 2012 05:30 Corrected Transcripts are verbatim transcripts that have been reviewed and corrected HENRY SCHEIN - World'Vest Base Business Risk   Financial Intelligence Services Limited (World Vest Base), Feb 2012, Pages: 1 financial advisor to see if it is appropriate for you. HENRY SCHEIN - World'Vest Base Business Risk HENRY SCHEIN - World'Vest Base Credit Risk   Financial Intelligence Services Limited (World Vest Base), Feb 2012, Pages: 1 for statistical black swans as past history is not a guarantee of continuation or reliability in the present or future. Speak to your financial advisor to see if it is appropriate for you. HENRY SCHEIN HENRY SCHEIN - World'Vest Base Dossier   Financial Intelligence Services Limited (World Vest Base), Feb 2012, Pages: 1 financial advisor to see if it is appropriate for you. HENRY SCHEIN - World'Vest Base Dossier William Blair Growth Stock Conference - Henry Schein, Inc., - Earnings Transcript   FactSet, June 2010 William Blair Growth Stock Conference - Henry Schein, Inc., - Earnings Transcript Tuesday, June 15, 2010 01:10 Corrected Transcripts are verbatim transcripts that have been reviewed and corrected Goldman Sachs Global Healthcare Conference - Henry Schein, Inc., - Earnings Transcript   FactSet, June 2010 Goldman Sachs Global Healthcare Conference - Henry Schein, Inc., - Earnings Transcript Thursday, June 17, 2010 03:00 Corrected Transcripts are verbatim transcripts that have been reviewed Barclays Capital Global Healthcare Conference - Henry Schein, Inc., - Earnings Transcript   FactSet, March 2010 Barclays Capital Global Healthcare Conference - Henry Schein, Inc., - Earnings Transcript Tuesday, March 23, 2010 06:30 Corrected Transcripts are verbatim transcripts that have been reviewed Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network